15:07:21 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-08-29 Kvartalsrapport 2024-Q2
2024-05-15 Årsstämma 2024
2024-04-25 Bokslutskommuniké 2023
2023-10-11 Extra Bolagsstämma 2023
2023-08-31 Kvartalsrapport 2023-Q2
2023-05-30 Ordinarie utdelning BRAINP 0.00 DKK
2023-05-26 Årsstämma 2023
2023-04-28 Bokslutskommuniké 2022
2022-09-29 Kvartalsrapport 2022-Q2
2022-09-02 Extra Bolagsstämma 2022
2022-05-19 Ordinarie utdelning BRAINP 0.00 DKK
2022-05-18 Årsstämma 2022
2022-04-29 Bokslutskommuniké 2021

Beskrivning

LandDanmark
ListaFirst North Denmark
SektorHälsovård
IndustriVård & Omsorg
Brain+ är verksamma inom läkemedelsbranschen. Bolaget är specialiserade inom forskning och utveckling för behandling av demens och alzheimers. Produktportföljen inkluderar exempelvis kognitiv stimuleringsterapi. Utöver huvudverksamheten erbjuds även service och tillhörande kringtjänster. Verksamheten drivs med störst närvaro inom Europa.
2023-11-02 16:47:55
 

· Effective from end of November 2023, Betül Susamis Unaran, member of the Board of Directors of Brain+, has resigned from her position for professional reasons

Copenhagen, Denmark, 2 November 2023 - Brain+ A/S (Nasdaq First North: BRAINP)

Brain+ A/S ("Brain+) announces that Betül Susamis Unaran, member of the company's Board of Directors, has today informed of her decision to resign from her board position, effective on 30 November. Betül was first elected to the board in September 2022, and her decision to leave her position is a consequence of changes in her other professional commitments.

Betül Susamis Unaran, board member, commented on her resignation:

"It has been a real pleasure to work on the board of Brain+ and to follow and contribute to the company's development over the past 14 months. Digital therapy is an area of high growth and with an immense potential - not least to help combat the global challenges of dementia. I am convinced that Brain+ stands in a unique position to become an important provider of digital dementia therapeutic to help millions of people living with the disease."

Brain+ thanks Betül for her valuable contributions and Chairman of the Board, Anders Härfstrand said:

"On behalf of the board and the company, I wish to express my sincere gratitude to Betül for her insightful and committed work during her tenure on the board. Her commercial experience and input have helped to advance the company, and It has been a pleasure working with Betül. We wish her all the best for the future.".

As of 1 December, the Board of Directors of Brain+ will count the following:

Anders Härfstrand, Chairman

Johan Luthman

Anish Shindore

In due course, Brain+ will be seeking to appoint a further board member candidate which will be proposed for election at a general meeting.

For more information about Brain+, please contact:

Kim Baden-Kristensen, CEO
Phone: +45 31 39 33 17
E-mail:kim@brain-plus.com

www.brain-plus.com

Certified Adviser

Keswick Global AG

Phone: +43 1740408 045

E-mail: info@keswickglobal.com